TipRanks on MSN
Vicore Pharma Raises $48 Million to Expand IPF Trial
An update from Vicore Pharma Holding AB ( ($SE:VICO) ) is now available. Vicore Pharma Holding AB has successfully raised approximately USD 48 ...
Treatment with Endeavor Biomedicines’ experimental oral therapy ENV-101 (taladegib) improved lung function in people with IPF ...
An announcement from Vicore Pharma Holding AB ( ($SE:VICO) ) is now available. Vicore Pharma Holding AB announced a directed share issue to raise ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback